Innovation
5 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 992 times.
| Year | Filings |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Social engagement
Social engagement: 5.8K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
7 investors on record; lead investors include Telegraph Hill Partners, Morgenthaler, Healthcare Ventures, High Country Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Angel & family office | 1 | 14% |
| Other / undisclosed | 1 | 14% |
Hiring activity
Hires occasionally
3 roles tracked across 2 of the last 12 months
8 Jan 2026 · Executive Partner & Office Operations Lead · Boulder
18 Nov 2025 · Digital Marketing Manager & Web Specialist · Boulder
2 Nov 2025 · Head of In Vivo Antibody Discovery (Director/Senior Director) · Boulder
24 Sep 2025 · Senior Associate Scientist (I/II), In Vivo Antibody Discovery · Boulder
Based on job postings tracked across public sources.